35 results · Page 1 of 2

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill PatientsCOVID-19, Coronaviridae Infections, Critical Illness, Disease Attributes, Infections, Nidovirales infectious disease, Nutritional and Metabolic Diseases, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, lung disorder, nutritional deficiency disease, nutritional disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia, vitamin D deficiency, vitamin deficiency disorderActive, not recruitingPhase 32026-10-09NCT03188796
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in EuropeDigestive System Diseases, Fibrosis, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute liver failure, chronic liver failure, cirrhosis of liver, liver disorder, liver failureRecruitingNot stated2026-10-08NCT07585890
Vorasidenib Maintenance for IDH Mutant AstrocytomaNeoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumorRecruitingPhase 32026-10-07NCT06809322
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)Arterial Occlusive Diseases, Ventricular Dysfunction, Ventricular Dysfunction, Left, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, heart failure, myocardial ischemia, systolic heart failure, vascular disorderRecruitingNot applicable2026-10-06NCT05427370
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Diseasedry eye syndrome, eye disorder, lacrimal apparatus disorderRecruitingNot applicable2026-09-29NCT05865457
Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain MetastasisBrain Metastases, Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-09-09NCT06315010
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.Advanced Breast Cancer; ER-positive Breast Cancer; ESR1 Gene Mutation; HER2-negative Breast CancerRecruitingPhase 32026-08-24NCT06382948
Cerebellar Mutism Syndrome StudyNeoplasms by Site, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system cancer, central nervous system disorder, communication disorder, language disorder, mutism, neoplasm, nervous system disorder, neurodevelopmental disorder, psychiatric disorder, speech disorderRecruitingNot stated2026-08-12NCT02300766
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal SubtypeAdvanced Breast Cancer; Advanced Breast Carcinoma; Hormone Receptor Positive Breast CarcinomaRecruitingPhase 22026-07-30NCT06486883
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patientssplenic marginal zone lymphomaActive, not recruitingPhase 32026-07-22NCT05735834
Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient TransferrinChemically-Induced Disorders, Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-related disorders, psychiatric disorder, substance-related disorderRecruitingNot stated2026-07-06NCT07632716
Tracking Results of Ablations to Combat AF Registry Generation 2Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorderRecruitingNot stated2026-06-29NCT05111015
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal NervesNeurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and SymptomsRecruitingNot stated2026-06-29NCT05110989
Optimizing the Use of Aspirin for the Prevention of PreeclampsiaFemale Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorderNot yet recruitingPhase 32026-06-24NCT07665853
Impact of a Tunneled Hemodialysis Catheter With Endexo® Technology on Catheter Dysfunction Compared With Historical Catheter Dysfunction Data in Standard CathetersChronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorderNot yet recruitingNot applicable2026-06-18NCT07655544
Diagnostic and Therapeutic Applications in Microarrays in Organ TransplantationDevelopment of Reporting System for Molecular Diagnosis; Incorporate Molecular Diagnosis Into Diagnostic Standards; Validation Study of Molecular Diagnostic SystemRecruitingNot stated2026-06-02NCT01299168
OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data ScienceInfarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderRecruitingNot stated2026-06-01NCT07619144
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)Secondary Hemophagocytic Lymphohistiocytosis (sHLH)RecruitingPhase 2 / Phase 32026-05-26NCT05416307
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registrycardiovascular disorder, heart disorder, heart valve disorder, mitral valve disorder, mitral valve insufficiencyRecruitingNot stated2026-05-07NCT04688190
Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative ColitisDigestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisActive, not recruitingPhase 22026-04-27NCT05177835
10°C vs 4°C Lung Preservation RCTLung Transplant; Organ PreservationActive, not recruitingNot applicable2026-03-19NCT05898776
Supramarginal Resection in GlioblastomaNeoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumorActive, not recruitingNot applicable2026-03-03NCT04243005
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational StudyFIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; Stage IA1 Endometrial Cancer FIGO 2023; Stage IA2 Endometrial Cancer FIGO 2023RecruitingNot stated2026-02-19NCT06689956
Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, disease, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasmRecruitingNot applicable2026-02-18NCT07418450
LETHE-AT: a Personalized Multidomain Lifestyle Intervention for Individuals at Increased Risk of Memory Impairment.Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyNot yet recruitingNot applicable2026-01-29NCT07376135